DAPAVILDA MET 10/100/1000

DAPAVILDA MET 10/100/1000 is a powerful triple-combination oral anti-diabetic formulation designed to help improve glycemic control in adults with Type 2 Diabetes Mellitus. It combines three well-established antidiabetic agents—Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg—into a single convenient tablet to support better blood sugar management, improved patient compliance, and enhanced metabolic control.

This medication is commonly prescribed when diet, exercise, and single or dual therapy are not sufficient to maintain optimal blood glucose levels.

What is DAPAVILDA MET 10/100/1000?

DAPAVILDA MET 10/100/1000 is a modern antidiabetic combination therapy formulated to address multiple pathways involved in high blood sugar levels. Each component plays a distinct role:

• Dapagliflozin reduces glucose reabsorption in kidneys
• Vildagliptin enhances insulin secretion and regulates glucagon levels
• Metformin improves insulin sensitivity and reduces hepatic glucose production

This triple-action approach helps in achieving better and more stable blood glucose control compared to monotherapy or dual therapy.

Composition & Strength

Each tablet of DAPAVILDA MET contains:

• Dapagliflozin – 10 mg
• Vildagliptin SR – 100 mg
• Metformin SR – 1000 mg

How DAPAVILDA MET Works (Mechanism of Action)

1. Dapagliflozin – SGLT2 Inhibitor

Dapagliflozin works by blocking the SGLT2 protein in the kidneys, preventing excess glucose reabsorption. This leads to glucose being excreted through urine, thereby lowering blood sugar levels.

2. Vildagliptin – DPP-4 Inhibitor

Vildagliptin increases incretin levels in the body. This helps:

• Stimulate insulin release after meals
• Reduce glucagon secretion
• Improve post-meal glucose control

3. Metformin – Biguanide

Metformin primarily works by:

• Reducing glucose production in the liver
• Improving insulin sensitivity in body tissues
• Enhancing peripheral glucose uptake

Together, these three mechanisms provide comprehensive glycemic control.

Key Benefits of DAPAVILDA MET 10/100/1000

• Helps manage Type 2 Diabetes effectively
• Triple mechanism for better glucose control
• Supports reduction in fasting and post-meal blood sugar
• Improves insulin sensitivity and pancreatic function
• May support weight neutrality or mild weight reduction (as part of overall management)
• Convenient once-daily combination tablet improves adherence
• Reduces pill burden compared to multiple separate medications

Indications

DAPAVILDA MET 10/100/1000 is generally indicated for:

• Type 2 Diabetes Mellitus in adults
• Patients not adequately controlled on dual therapy
• Individuals requiring multi-mechanism glucose control approach

It should be used along with proper diet control, exercise, and lifestyle modification.

Dosage & Administration

• To be taken strictly as prescribed by a healthcare professional
• Usually taken once daily with meals to reduce gastric discomfort
• Swallow whole with water; do not crush or chew SR tablets
• Dosage may vary depending on blood sugar levels, kidney function, and patient response

Important: Never adjust dosage without medical supervision.

Possible Side Effects

Like all medications, DAPAVILDA MET 10/100/1000 may cause some side effects. Common ones may include:

• Nausea or stomach upset
• Diarrhea
• Headache
• Urinary tract infections (due to increased glucose excretion)
• Genital fungal infections
• Mild dizziness

Rare but serious effects should be reported immediately to a doctor.

Precautions & Warnings

Before using this medication, patients should inform their doctor if they have:

• Kidney or liver impairment
• History of diabetic ketoacidosis
• Heart disease
• Dehydration or frequent infections
• Pregnancy or breastfeeding status

Avoid excessive alcohol intake as it may increase risk of lactic acidosis (related to Metformin).

Drug Interactions

DAPAVILDA MET may interact with:

• Diuretics
• Insulin or other antidiabetic drugs
• Corticosteroids
• Thyroid medications
• Certain antihypertensive drugs

Always inform your doctor about all ongoing medications.

Storage Instructions

• Store in a cool, dry place below 25°C
• Protect from moisture and direct sunlight
• Keep out of reach of children
• Do not use expired medication

Who Should Use DAPAVILDA MET?

This medication is suitable for:

• Adults diagnosed with Type 2 Diabetes
• Patients requiring combination therapy for better sugar control
• Individuals who need improved adherence with a single tablet regimen

It is not intended for Type 1 Diabetes or diabetic ketoacidosis management.

Why Choose DAPAVILDA MET 10/100/1000?

The unique triple-action formula of DAPAVILDA MET provides a scientifically balanced approach to diabetes management. By combining the renal, pancreatic, and hepatic pathways, it offers comprehensive glycemic control under a single tablet format.

This helps both patients and healthcare providers streamline treatment while targeting multiple causes of high blood sugar.

Conclusion

DAPAVILDA MET 10/100/1000 is an advanced triple-combination antidiabetic medication that integrates Dapagliflozin, Vildagliptin SR, and Metformin SR into one powerful tablet. It is designed to support effective blood glucose control in Type 2 Diabetes patients while improving convenience and treatment adherence.